Viewing Study NCT01138267


Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2025-12-25 @ 10:40 PM
Study NCT ID: NCT01138267
Status: COMPLETED
Last Update Posted: 2020-07-17
First Post: 2010-06-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV)
Sponsor: The HIV Netherlands Australia Thailand Research Collaboration
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: HIV-NAT103
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER_GOV View
None OTHER View
None OTHER View